Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates

Similar documents
Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred

Medicare Part D 2016 Formulary Changes Desert Preferred Choice

Medicare Part D 2015 Formulary Changes Desert Preferred Choice

Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred

Aetna Better Health of Illinois Medicaid Formulary Updates

Network Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary

2018 CareOregon Advantage Part D Formulary Changes

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

FirstCarolinaCare Insurance Company. Step Therapy Requirements

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

Step Therapy Requirements. Effective: 11/01/2018

SecureBlue Formulary 2016 Master Negative Changes from 2015 to 2016

August 2016 Formulary Updates

Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum

Step Therapy Requirements. Effective: 1/1/2019

ANTIDIABETIC AGENTS - MISCELLANEOUS

Health Partners Medicare Prime 2019 Formulary Changes

ANTIDIABETIC AGENTS - MISCELLANEOUS

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Medicare Part D 2017 Formulary Changes OC Preferred

True Health New Mexico List of Medications with Quantity Limits

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTICONVULSANTS. Details

Memorial Hermann Advantage HMO February 2019 Formulary Addendum

ANTICONVULSANTS. Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTICONVULSANTS. Details

Aetna Better Health FIDA Plan

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Partners Notice of Change March 2017

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

December 2016 Formulary Updates

Medicare Part D 2017 Formulary Changes Service To Senior

Medicare Part D 2012 Formulary Changes Service To Senior and Total Fit

Step Therapy Requirements. Effective: 05/01/2018

Medicare Part D 2017 Formulary Changes OC Preferred

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Step Therapy Requirements. Effective: 12/01/2016

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies

**CRITERIA UNDER CMS REVIEW**

Step Therapy Requirements

Medicare Part D 2017 Formulary Changes Service To Senior

ANTICONVULSANTS. Details

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

Pharmacy Updates Summary

VIVA MEDICARE IMPORTANT T EXPANDED PERFORMANCE FORMULARY UPDATES

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

Health Partners Medicare Special 2018 Formulary Changes

2018 Formulary Notice of Change Prescription Drug Plans

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

November 2016 Formulary Updates

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

UPDATE Ohana QUEST Integration Medicaid

Medicare Part D 2017 Formulary Changes OC Preferred

2016 FORMULARY ADDENDUM NOTICE OF CHANGE

2016 Medicare Part D Formulary Change

VIVA Health, Inc. Part D Cumulative Formulary Changes for 2009

2018 Medicare Part D Formulary Change

Rationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs)

Quarterly pharmacy formulary change notice

2018 Step Therapy Criteria

NOTIFICATION OF FORMULARY CHANGES

WellCare s South Carolina Preferred Drug List Update

WellCare s South Carolina Preferred Drug List Update

December 2016 Formulary Updates

2018 Medicare Part D Formulary Change

WVCH Formulary Additions Effective 01/01/2016 Name Strength Dosage Form Route Formulary Restrictions

Step Therapy Requirements

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

Quarterly pharmacy formulary change notice

2018 Formulary Update

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

March 2017 P&T Updates

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

2017 Formulary Addendum Notice of Change

2017 Step Therapy Criteria

Quarterly pharmacy formulary change notice

Quarterly Pharmacy Formulary Change Notice

2017 Formulary Addendum Notice of Change (Prescription Drug Plans)

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

Quarterly pharmacy formulary change

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

ALLERGIC CONJUNCTIVITIS AGENTS

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

Neighborhood Medicaid Formulary Changes: June 2017

March 2018 P & T Updates

Quarterly pharmacy formulary change notice

JULY 2017 ADDITIONS. NP Thyroid 120mg NP Thyroid 15mg JUNE 2017 CHANGES

Transcription:

Aetna Better Health Illinois Premier Plan November 2015 Formulary Updates desogestrel & ethinyl estradiol tab 0.15 mg-30 mcg RIVASTIGMINE DIS 13.3/24; QL (30 patches/30 days) RIVASTIGMINE DIS 4.6MG/24; QL (30 patches/30 days) RIVASTIGMINE DIS 9.5MG/24; QL (30 patches/30 days) ARIPIPRAZOLE SOL 1MG/ML; ST required BRILINTA TAB 60MG REXULTI TAB 0.25MG; QL (360 tabs/30 days) REXULTI TAB 0.5MG; QL (180 tabs/30 days) REXULTI TAB 1MG; QL (90 tabs/30 days) REXULTI TAB 2MG; QL (60 tabs/30 days) REXULTI TAB 3MG; QL (30 tabs/30 days) REXULTI TAB 4MG; QL (30 tabs/30 days) TETRABENAZIN TAB 12.5MG; PA, QL (240 tabs/30 days) TETRABENAZIN TAB 25MG; PA, QL (120 tabs/30 days) VIIBRYD KIT STARTER TEKAMLO TAB 300-10MG October 2015 Formulary Updates DACARBAZINE INJ 100MG (PA required) DOCETAXEL INJ 20MG/2ML (PA required) ESOMEPRAZOLE CAP 20 MG ESOMEPRAZOLE CAP 40 MG BEXAROTENE CAP 75MG (PA required) DOCETAXEL INJ 160/16ML (PA required) FARXIGA TAB 10MG (QL 30 tabs/30 days)

FARXIGA TAB 5MG (QL 60 tabs/30 days) GLEOSTINE CAP 100MG GLEOSTINE CAP 10MG GLEOSTINE CAP 40MG IRESSA 250MG (PA required) KINRIX INJ MEGESTROL SUS 625MG/5M (PA required) NAMZARIC CAP 14-10MG NAMZARIC CAP 28-10MG ORKAMBI TAB 200-125 (PA required) QUADRACEL INJ XIGDUO XR TAB 10-1000 (QL 30 tabs/30 days) XIGDUO XR TAB 10-500MG (QL 30 tabs/30 days) XIGDUO XR TAB 5-1000MG (QL 60 tabs/30 days) XIGDUO XR TAB 5-500MG (QL 60 tabs/30 days) APEXICON OIN 0.05% FOSCARNET INJ 24MG/ML TEKAMLO TAB 300-5MG September 2015 Formulary Updates ASPIRIN/DIPYRIDAMOLE CAP 25-200MG MEMANTINE TAB HCL 5MG; PA MEMANTINE HC TAB 10MG; PA TRULICITY INJ 0.75/0.5; QL TRULICITY INJ 1.5/0.5; QL GLATOPA (glatiramer acetate) INJ 20MG/ML; PA, QL LINEZOLID TAB 600MG ABILIFY SOL 1MG/ML

August 2015 Formulary Updates ALOSETRON TAB 0.5MG; PA ALOSETRON TAB 1MG; PA CLINDAMAX GEL 1% GAVILYTE-H KIT KIMIDESS TAB BEXSERO INJ BREO ELLIPTA INH 200-25; QL CLOZAPINE TAB 150MG/ODT; PA; QL CLOZAPINE TAB 200MG/ODT; PA; QL KUVAN POW 500MG; PA July 2015 Formulary Updates ARIPIPRAZOLE TAB 10MG; QL ARIPIPRAZOLE TAB 15MG; QL ARIPIPRAZOLE TAB 20MG; QL ARIPIPRAZOLE TAB 2MG; QL ARIPIPRAZOLE TAB 30MG; QL ARIPIPRAZOLE TAB 5MG; QL

LEVONOR/ETHI TAB 0.1-0.02 FARYDAK CAP 10MG; PA FARYDAK CAP 15MG; PA FARYDAK CAP 20MG; PA FENTORA TAB 100MCG; PA; QL FENTORA TAB 200MCG; PA; QL FENTORA TAB 400MCG; PA; QL FENTORA TAB 600MCG; PA; QL FENTORA TAB 800MCG; PA; QL SAPHRIS SUBLINGUAL 2.5MG; QL TOUJEO SOLO INJ 300IU/ML TUDORZA PRES AER 30 doses; QL ABILIFY SOL 1MG/ML AMTURNIDE TAB 150-5-12.5 AMTURNIDE TAB 300-10-12.5 AMTURNIDE TAB 300-10-25MG AMTURNIDE TAB 300-5-12.5 AMTURNIDE TAB 300-5-25MG ANDROXY TAB 10MG PEDI-DRI POW 100000 CUBICIN SOL 500MG VANCOMYCIN INJ 1000MG VANCOMYCIN INJ 10GM June 2015 Formulary Updates CEFIXIME SUS 100/5ML CEFIXIME SUS 200/5ML CORMAX SCALP SOL 0.05% FLUOCIN ACET OIL SCALP TAZICEF INJ 2GM

ZENATANE CAP 30MG CHANTIX PAK 1MG; PA GARDASIL 9 INJ LENVIMA CAP 10MG; PA LENVIMA CAP 14MG; PA LENVIMA CAP 20MG; PA LENVIMA CAP 24MG: PA LEVETIRACETAM INJ 10MG/ML LEVETIRACETAM INJ 15MG/ML LEVETIRACETAM INJ 5MG/ML MOVANTIK TAB 12.5MG; QL MOVANTIK TAB 25MG; QL PAZEO DROPS 0.7% PRIFTIN TAB 150MG PRISTIQ TAB 25MG; QL ZYPREXA RELP INJ 210MG; B/D ZYPREXA RELP INJ 300MG; B/D ZYPREXA RELP INJ 405MG; B/D BARACLUDE TAB 0.5MG BARACLUDE TAB 1MG CELEBREX CAP 100MG CELEBREX CAP 200MG CELEBREX CAP 400MG CELEBREX CAP 50MG CELLCEPT SUS 200MG/ML DIOVAN TAB 160MG DIOVAN TAB 320MG DIOVAN TAB 40MG DIOVAN TAB 80MG EXFORGE TAB 10-160MG EXFORGE TAB 10-320MG EXFORGE TAB 5-160MG EXFORGE TAB 5-320MG EXFORGE HCT/10- TAB 160-12.5 EXFORGE HCT/10- TAB 160-25 EXFORGE HCT/10- TAB 320-25 EXFORGE HCT/5- TAB 160-12.5 EXFORGE HCT/5- TAB 160-25 INTUNIV TAB 1MG

INTUNIV TAB 2MG INTUNIV TAB 3MG INTUNIV TAB 4MG MAFENIDE ACE PAK 5% PATANASE SPR 0.6% RAPAMUNE TAB 1MG RAPAMUNE TAB 2MG SUPRAX TAB 400MG VALCYTE TAB 450MG ZYVOX SOL 2MG/ML May 2015 Formulary Updates TRUMENBA INJ PREZCOBIX TAB 800-150 EVOTAZ TAB 300-150 NUTRILIPID EMU 20% IBRANCE CAP 100MG, 125MG, 75MG ILOTYCIN OIN OP DOXY 100 INJ 100MG APEXICON OIN 0.05% April 2015 Formulary Updates LYNPARZA CAP 50MG REYATAZ POW 50MG VITEKTA TAB 150MG RELISTOR KIT 12/0.6ML VITEKTA TAB 85MG

deblitane tab 0.35MG tarina fe tab 1/20 digitek tab 0.125MG digitek tab 0.25MG ivermectin tab 3MG deso/ethinyl estradiol tab Generics Removed RELISTOR INJ 12/0.6ML March 2015 Formulary Updates CERDELGA capsule 84 mg, PA HARVONI tablet 90-400 mg, PA HUMIRA injection 10 mg/0.2, PA OCTAGAM injection 2gm/20ml, PA PURIXAN suspension 20mg/ml SPIRIVA RESPIMAT, QL TREANDA injection 180/2 ml, B vs D TREANDA injection 45/0.5 ml, B vs D ZENPEP capsule 40000 unit GAMUNEX-C INJ 40/400ML, PA amlodipine/valsartan/hctz tablet 5-160-12.5 mg, 5-160-25 mg, 10-160-12.5, 10-160-25 mg; QL amlodipine/valsartan/hctz tablet 10-320-25 mg celecoxib capsule 50 mg, 100 mg, 200 mg, 400 mg; QL guanfacine tablet er, 1 mg, 2 mg, 3 mg, 4 mg lamivudine oral solution 10mg/ml linezolid injection 2mg/ml mycophenolate suspension 200mg/ml; B vs. D olopatadine spray 0.6% potassium chloride tablet 8meq er sirolimus tablet 1mg, 2 mg; B vs. D valganciclovir tablet 450 mg levonorgestrel & ethinyl estradiol (91-day) tab 0.15-0.03 mg Brands Removed HEPARIN SODIUM/NACL injection 1000 unit PRIFTIN tablet 150 mg

TIMENTIN injection 3.1 g, 31g Generics Removed e.s.p. suspension 200-600 mg ees/sulfisoxazole suspenson 200-600 mg e.s.p. suspension 200-600 mg PROMACTA TAB 12.5MG-QL from 240 amount, 30 days increased to 360 amount, 30 days PROMACTA TAB 25MG-QL from 120 amount, 30 days increased to 180 amount, 30 days PROMACTA TAB 50MG-QL from 60 amount, 30 days increased to 90 amount, 30 days PROMACTA TAB 75MG-QL from 60 amount, 30 days increased to 30 amount, 30 days January 2015 Formulary Updates CYCLOPHOSPHAMIDE Capsule 25 mg, 50mg, PA, B vs D REVATIO Suspension 10 mg/ml, QL, PA SOMAVERT Injection 25mg, 30mg, PA TRIUMEQ Tablet TYBOST Tablet 150mg XARELTO STARTER PACK Tablet 15/20 mg Amlodipine/valsartan Tablet 5-160 mg, 5-320 mg, 10-160 mg, QL Amlodipine/valsartan Tablet 10-320 mg SHAROBEL Tablet 0.0.35 mg Amlodipine/valsartan Tablet 5-160 mg, 5-320 mg, 10-160 mg, QL Amlodipine/valsartan Tablet 10-320 mg SHAROBEL Tablet 0.0.35 mg Amlodipine/valsartan Tablet 5-160 mg, 5-320 mg, 10-160 mg, QL Amlodipine/valsartan Tablet 10-320 mg SHAROBEL Tablet 0.0.35 mg Changes NAMENDA XR Capsules 7 mg, 14 mg, removed QL NAMENDA Tablet 5 mg, 10 mg, PA added NAMENDA XR Capsules 7 mg, 14 mg, removed QL